AZN Option Call 17-01-2025 37 Option on AstraZeneca PLC ADR
AZN Stock | USD 67.39 0.21 0.31% |
AZN Option Call 17-01-2025 37 is a CALL option contract on AstraZeneca PLC's common stock with a strick price of 37.5 expiring on 2025-01-17. The contract was last traded on 2024-11-07 at 11:30:07 for $26.99 and, as of today, has 37 days remaining before the expiration. The option is currently trading at a bid price of $28.75, and an ask price of $33.4. The implied volatility as of the 11th of December 2024 is 37.0.
AstraZeneca |
The strike price represents the predetermined price at which a call buyer can buy AstraZeneca Stock. Call options may be purchased for speculation or sold for income purposes, or simply combined for various spread or combination strategies. If AstraZeneca PLC's price is above the strike price at expiry, the profit is the current AstraZeneca PLC's stock price, minus the strike price and the premium.
Rule 16 of 2025-01-17 Option Contract
The options market is anticipating that AstraZeneca PLC ADR will have an average daily up or down price movement of about 0.0952% per day over the life of the option. With AstraZeneca PLC trading at USD 67.39, that is roughly USD 0.0642. If you think that the market is fully understating AstraZeneca PLC's daily price movement you should consider buying AstraZeneca PLC ADR options at that current volatility level of 1.52%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
In The Money Call Option on AstraZeneca PLC
An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their AstraZeneca PLC positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on AstraZeneca Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Call Contract Name | AZN Option Call 17-01-2025 37 |
Expires On | 2025-01-17 |
Days Before Expriration | 37 |
Last Traded On | 2024-11-07 11:30:07 |
Open Interest | 67 |
Current Trading Volume | 1.0 |
Strike Price | 37.5 |
Last Traded At | 26.99 |
Current Price Spread | 28.75 | 33.4 |
Rule 16 Daily Up or Down | USD 0.0642 |
AstraZeneca long CALL Option Payoff at expiration
Buying AstraZeneca PLC's call option is the simplest of option trades. A call option on AstraZeneca Stock gives investors the right (but not the obligation) to purchase AstraZeneca PLC at the given strike price. Therefore AstraZeneca PLC's call intrinsic value or payoff at expiration depends on where the AstraZeneca Stock price is relative to the call option strike price. The strike price of 37.5 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and negative (the trade is a loss). Above the strike, the payoff line is upward sloping as the option payoff rises in proportion with AstraZeneca PLC's price. Finally, at the break-even point of 37.5, the line crosses zero, and trading AstraZeneca becomes profitable.
Profit |
AstraZeneca PLC Price At Expiration |
AstraZeneca short CALL Option Payoff at expiration
By selling AstraZeneca PLC's call option, the investors signals his or her bearish sentiment. A short position in a call option written on AstraZeneca PLC will generally make money when the underlying price goes down. Therefore AstraZeneca PLC's call intrinsic value or payoff at expiration depends on where the AstraZeneca Stock price is relative to the call option strike price. The strike price of 37.5 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and positive (the seller makes a profit). Above the strike, the payoff line is downward sloping as the option payoff drops in proportion to AstraZeneca PLC's price. Finally, at the break-even point of 37.5, the line crosses zero, and trading AstraZeneca becomes disadvantageous with no downside limits.
Profit |
AstraZeneca PLC Price At Expiration |
AstraZeneca PLC ADR Available Call Options
AstraZeneca PLC's option chain is a display of a range of information that helps investors for ways to trade options on AstraZeneca. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for AstraZeneca. It also shows strike prices and maturity days for a AstraZeneca PLC against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
AstraZeneca PLC Corporate Directors
Marc Dunoyer | Chief Financial Officer, Executive Director | Profile | |
Sherilyn McCoy | Non-Executive Independent Director | Profile | |
Genevieve Berger | Non-Executive Independent Director | Profile | |
Nazneen Rahman | Non-Executive Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.034 | Dividend Share 2.97 | Earnings Share 2.07 | Revenue Per Share 2.7424 | Quarterly Revenue Growth 0.18 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.